Zobrazeno 1 - 10
of 73
pro vyhledávání: '"low grade serous ovarian carcinoma"'
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Externí odkaz:
https://doaj.org/article/d85da56948ef457a9204c3dda6d147c4
Autor:
Brad Nakamura, Rosemary Senguttuvan, Nora H. Ruel, Paul H. Frankel, Susan E. Yost, Sarah Cole, Sue Chang, Alexander Jung, Melissa Eng, Raechelle Tinsley, Daphne Stewart, Edward Wang, Joshua Cohen, Jeannine Villella, Richard L. Whelan, Amit Merchea, Danielle K. DePeralta, Mihaela Cristea, Mark T. Wakabayashi, Mustafa Raoof, Thanh Hue Dellinger
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionLow grade serous ovarian carcinoma (LGSOC) is a rare subtype of ovarian cancer (OC) that is challenging to treat due to its relative chemoresistance. Given that LGSOC patients often recur in the peritoneal cavity, novel intraperitoneal (I
Externí odkaz:
https://doaj.org/article/6bec2ec2e11647dab2a24f0674491ac4
Immunoexpression of p53 and p16 in Low and High-grade Serous Ovarian Cancer: A Cross-sectional Study
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 17, Iss 11, Pp 18-22 (2023)
Introduction: The most common malignancy of the ovary is serous carcinoma, which can be classified as either Low-grade Serous Ovarian Carcinoma (LGSOC) or High-grade Serous Ovarian Carcinoma (HGSOC) and originates from the surface epithelium. How
Externí odkaz:
https://doaj.org/article/133a139160294acca50f249f2860c44c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kamrunnahar Shanta, Kentaro Nakayama, Mohammad Mahmud Hossain, Sultana Razia, Tomoka Ishibashi, Masako Ishikawa, Hitomi Yamashita, Kosuke Kanno, Seiya Sato, Satoru Nakayama, Yoshiro Otsuki, Satoru Kyo
Publikováno v:
Current Oncology, Vol 29, Iss 6, Pp 4020-4033 (2022)
Few studies have reported hormonal agent use in the treatment of low-grade serous ovarian carcinomas (LGSOCs), which are chemoresistant. Considering the need for novel effective therapies, we investigated the hormone receptor expression and hormonal
Externí odkaz:
https://doaj.org/article/f5479f79dc62452ebb15729e520a7265
Autor:
Jutta Huvila, Dawn R Cochrane, Monica Ta, Christine Chow, Kendall Greening, Samuel Leung, Anthony N Karnezis, Analisa DiFeo, David G Huntsman
Publikováno v:
The Journal of Pathology: Clinical Research, Vol 7, Iss 6, Pp 548-555 (2021)
Abstract Ovarian carcinoma histotypes are distinct diseases with variable clinical outcomes and response to treatment. There is a need for new subtype‐specific treatment modalities, especially for women with widespread and chemo‐resistant disease
Externí odkaz:
https://doaj.org/article/d0a536b413fe4de3a25e878efa4fee34
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Diagnostics, Vol 12, Iss 2, p 458 (2022)
Low-grade serous carcinoma (LGSC) of the ovary is a rare histological subtype of epithelial ovarian carcinoma. It has distinct clinical behavior and a specific molecular profile. Compared with high-grade serous carcinoma, this tumor presents at a you
Externí odkaz:
https://doaj.org/article/f9d98c5e42c2439b9607dd8fc985b6af
Autor:
Analisa DiFeo, Monica Ta, Christine Chow, Anthony N. Karnezis, Samuel Leung, David G. Huntsman, Kendall Greening, Jutta Huvila, Dawn R. Cochrane
Publikováno v:
The Journal of Pathology: Clinical Research, Vol 7, Iss 6, Pp 548-555 (2021)
The Journal of Pathology: Clinical Research
The journal of pathology. Clinical research, vol 7, iss 6
The Journal of Pathology: Clinical Research
The journal of pathology. Clinical research, vol 7, iss 6
Ovarian carcinoma histotypes are distinct diseases with variable clinical outcomes and response to treatment. There is a need for new subtype‐specific treatment modalities, especially for women with widespread and chemo‐resistant disease. Stimula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db2a0c0bf8c48b4636edd40dc7c7f5fc
https://doaj.org/article/d0a536b413fe4de3a25e878efa4fee34
https://doaj.org/article/d0a536b413fe4de3a25e878efa4fee34